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Abstract
Aims/hypothesis Under conditions of insulin resistance and
type 2 diabetes, fat cells are subjected to increased levels of
insulin, which may have a major impact on the secretion of
adipokines.
Materials and methods Using transcriptomics and proteo-
mics, we investigated how insulin affects the transcription
and protein secretion profile of mature 3T3-L1 adipocytes.
Results We found that insulin has a significant impact on
protein secretion of 3T3-L1 adipocytes. However, tran-
scription is not the major regulation point for these secreted
proteins. For extracellular matrix components, our data
suggest that the mRNA level of processing enzymes, but
not of target proteins, is the regulating point at which
insulin stimulates secretion and function of the relevant
proteins. Among these enzymes, we report a novel finding,
namely that sulfatase 2 gene is regulated by insulin, which
may induce a functional change in cultured adipocytes.
Conclusions/interpretation We propose that enhancement
of protein processing and secretion rather than transcription
of the secreted protein genes is part of the strategic role of
insulin in the induction of cellular responses.
Keywords Adipocytes . Insulin . Proteomics . Secretion .
Transcriptomics
Abbreviations
1D one-dimensional
2D two-dimensional
ECM extracellular matrix
ESM Electronic Supplementary Material
Glc low insulin high glucose condition
HSPG heparan sulfate proteoglycans
Ins high insulin low glucose condition
Ins+Glc high insulin high glucose condition
MALDI-
TOF
matrix assisted laser desorption/ionisation-time
of flight
P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxy-
genase (proline 4-hydroxylase), alpha 1
Pcolce procollagen C-endopeptidase enhancer protein
PTM post-translational modification
Q-PCR quantitative real time RT-PCR analysis
SPARC secreted acidic, cysteine-rich protein
Sulf 2 sulfatase 2
Introduction
Obesity is associated with insulin resistance and type 2
diabetes, implying that adipose tissue plays a role in the
development of these disorders [1]. The primary function of
adipose tissue is storage of fat, but it is also recognised as
an active regulation centre, providing signals to guide
metabolism. Well-known examples of signalling molecules
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(adipokines) secreted by adipose tissue are leptin, adipo-
nectin, resistin and IL-6 [2]. Adipokine secretion is
responsive to afferent messages to the fat cells [3]. Under
conditions of insulin resistance and type 2 diabetes, fat cells
are subjected to increased levels of insulin, which may have
a major impact on the adipokines. A number of reviews
have provided overviews of the relation between circulating
levels of insulin and specific adipokines in rodents and
humans [2, 4]. According to these, IL-6 and leptin have
shown a consistently positive relation with insulin in various
studies, while the response of resistin and adiponectin to
insulin remains contradictory.
Often a high level of insulin is associated with
hyperglycaemia. Only in the first stage of insulin
resistance or at the later stage of type 2 diabetes do high
insulin and high glucose not appear in parallel. As insulin
targets, adipocytes respond to insulin by enhancing
glucose uptake, which is impaired in insulin resistance
and type 2 diabetes [5]. High levels of glucose alone may
induce the production of inflammatory factors and acute-
phase reactants in adipocytes [6]. However, in in vivo
investigations of obesity and type 2 diabetes, the contribu-
tions from high insulin and/or high glucose were hardly
distinguished [2].
The effect of insulin on protein secretion has been
addressed specifically in vitro using mouse 3T3-L1 adipo-
cytes. It was shown that insulin can stimulate exocytosis of a
regulated secretory compartment containing adiponectin,
which is distinct from that containing type VI alpha 3
collagen [7]. Another study indicated that insulin stimulates
the activity of the constitutive secretory pathway, possibly
by increasing the activity of phospholipase D [8]. Despite
the information obtained, these studies also showed that
the mechanism of protein secretion regulation by insulin
in adipocytes is complex and warrants further detailed
study.
‘Omics’ technology provides powerful tools for expres-
sion profiling of biological events. Numerous studies have
used genomics-approaches to investigate insulin actions in
relation to insulin resistance and type 2 diabetes, but only
few specifically addressed the effect of insulin on adipocyte
secretion [9]. In our previous work we set up a two-
dimensional (2D) gel-secreted protein map of mouse 3T3-
L1 adipocytes [10]. In addition to lipid metabolism
regulators and growth factors, we found that the majority
of secreted proteins belong to extracellular components and
their related proteins. Here, using transcriptomics and
proteomics, we investigated how insulin affects the tran-
scription and protein secretion profile of mature 3T3-L1
adipocytes. As insulin stimulates glucose uptake and
differences in intracellular glucose levels may affect gene
expression, we performed our studies under conditions of
low and high glucose.
Materials and methods
Cell culture and sample preparation
Murine 3T3-L1 fibroblasts (American Type Culture Col-
lection, ATCC Number: CL-173) were cultured and
differentiated to adipocytes in vitro as previously described
[10], except that in the adipogenic cocktail 1 μmol/l 15-
deoxy-Δ12,14-prostaglandin J2 (Cayman Chemical, Ann
Arbor, MI, USA) was used instead of 10 μmol/l prostaglan-
din I2 (Carbacyclin). On day 8, differentiated cells grown in
DMEM/F-12 (1:1) medium supplemented with 10% fetal
calf serum (Perbio Science, Erembodegem, Belgium) were
treated with 1 μmol/l insulin (cat. no. I 1882; Sigma,
Zwijndrecht, the Netherlands) and 4.5 mmol/l glucose (high
insulin low glucose condition [Ins]) or 15.75 mmol/l glucose
(high insulin high glucose condition [Ins+Glc]). In parallel,
control cells were cultured in the same medium with
4.5 mmol/l glucose alone (Basal) or 15.75 mmol/l glucose
alone (low insulin high glucose condition, [Glc]). Each
condition had quadruplicates. The Ins vs basal conditions
were used to monitor the effect of insulin at the low glucose
level; the Ins+Glc vs Glc conditions were used to do the
same at the high glucose level. On day 10, two replications
with approximately 2.6×106 cells of all conditions were
collected separately for total RNA isolation using Trizol
(Invitrogen, Breda, the Netherlands) according to the
manufacturer’s instruction, and after chloroform extraction,
an extraction of phenol: chloroform: isoamylalcohol
(25:24:1), followed by a chloroform extraction, was added.
Quality and quantity of total RNA were checked by
spectrophotometer and agarose gel. Cells of the two other
replications with approximately 7×106 cells were washed
and incubated with the corresponding serum-free medi-
um, supplemented with 2.2 mg/l transferrin and
10.6 nmol/l sodium selenite, for 6 h. The number of
cells was counted and culture medium proteins were
collected, dialysed, lyophilised and dissolved as described
before [10]. The duplicated protein samples were pooled
for later analysis. Three independent experiments were
performed.
Microarray
The mouse 50-mer 10K_A oligo set (MWG, Ebersberg,
Germany) and additional 50-mer oligonucleotides of genes
encoding secretory proteins and proteins involved in energy
metabolism were printed in-house on GAP II-coated glasses
(Corning, Acton, MA, US) using a Microgrid II arrayer
(BioRobotics, Cambridge, UK). A total of 10,117 (10,060
non-redundant) mouse oligo probes was arrayed. In addition
to the manufacturer’s annotation, the oligonucleotides were
further annotated with Gene Ontology using SOURCE
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http://smd.stanford.edu/cgi-bin/source/sourceBatchSearch,
last accessed 28 October 2005).
We used five total RNA samples of three independent
experiments per condition for hybridisation of the oligo
DNA arrays as described [11]. For this, total RNA samples
were reverse transcribed (45 μg scale) to cDNA and
labelled with Cy5 using a direct labelling method as
described [12]. A pool of total RNA from all samples
labelled with Cy3 was used as a 1:1 (v/v) reference in the
hybridisations. The signals were captured by ScanArray
Express HT (PerkinElmer Life Sciences, Billerica, MA,
US) at 90% laser power and 60% photomultiplier tube
voltage.
Microarray data analysis
The data were extracted (medium density) using ArrayVi-
sion (version 7.0, Imaging Research, St Catharines, ON,
Canada). The overall quality of the slides was checked both
by visual inspection and Bland–Altmen plots. Next, the
eligible array data were exported into GeneMaths XT
(Applied Maths, Sint-Martens-Latem, Belgium). Spots with
an average intensity, over all arrays, of lower than two-fold
above average background were removed from further
analysis. Then, the Cy5 intensities of the remaining 4,019
spots were normalised against the Cy3 reference exactly as
described [11]. The differences between samples were
visualised using GeneMaths embedded discriminant analy-
sis. This is a supervised form of principal component
analysis, based on all expression data, and in which
samples are first assigned to their treatment group and then
separated along the dimension of maximum variation in
gene or protein expression between the groups. Individual
spots with a signal more than two-fold different from the
average of the replicates (n=5) were excluded and flagged.
Fold change calculations and Student t-tests were per-
formed in Microsoft Excel. Fold change equals ratio in the
case of increase or equals −1/ ratio in the case of decrease.
Cut-off criteria for differential expression was set at a fold
change of >1.3 and p<0.05. For genes with replicated spots,
the average value of individual spots was used.
Quantitative real-time RT-PCR
All six total RNA samples per treatment were used in
quantitative real-time RT-PCR analysis (Q-PCR) of 18
genes (primer information, see Electronic Supplementary
Material [ESM] Table 1). After cDNA synthesis using an
iScript kit (Bio-Rad, Veenendaal, the Netherlands), Q-PCR
was conducted in iQ SYBR Green Supermix (MyiQ Single-
Color Real-Time PCR Detection System; Bio-Rad), accord-
ing to the manufacturer’s instructions. The standard curve
method was used in Q-PCR data analysis. Ribosomal
protein S15 was selected as reference gene on the basis of
its constant expression behaviour on the array.
One- and two-dimensional gel electrophoresis
Protein samples obtained from 2.4×106 cells of each
condition were analysed by 2D gel electrophoresis as
described [10]. The data were obtained from PDQuest
(version 7.2; Bio-Rad) and the gel density was normalised
on the basis of total quantity in a spiked set of molecular
weight markers. The gels were matched to a secreted
protein reference map for 3T3-L1 adipocytes [10] and 99
secreted spots of <85 kDa were matched. The data were
exported into GeneMaths for discriminant principal com-
ponent analysis. A 1.8-fold change was taken as cut-off for
regulation. Protein samples obtained from 2.2×105 cells
were separated using 18-cm one-dimensional (1D) SDS-
PAGE (Protean II XL; Bio-Rad) to analyse high-molecular-
weight proteins. After silver staining [10], gel images were
obtained with a GS-800 calibrated densitometer and
analysed with Quantity One (Bio-Rad). An adipocyte
medium protein sample treated with Brefeldin A [10] was
loaded on the same gel, to verify protein secretion. Protein
bands were excised and identified by matrix assisted laser
desorption/ionisation-time of flight (MALDI-TOF) mass
spectrometry [13].
Results
Insulin generates minor changes in the transcriptome
of mature adipocytes in vitro
To investigate the effect of insulin on mature adipocytes,
3T3-L1 adipocytes were cultured for 2 days with
1 μmol/l insulin with either high glucose or low glucose.
For reference, cells were cultured with high or low glucose
only. The morphology of the adipocytes as examined by
light microscopy was similar for all four conditions. Total
RNA samples from three independent experiments, per-
formed in duplicate for each of the four conditions, were
individually hybridised against a common reference pool
on oligo DNA arrays. Two arrays were excluded from the
analysis for quality reasons, one for Ins+Glc and the other
for Ins. A total of 4,019 of 10,117 probes with average
signals higher than two-fold over the background signal
and representing 3,718 non-redundant genes were used for
further data analysis. The comparison between the insulin
and non-insulin treatment at the same glucose level showed
minor changes in the transcriptome. No gene changed >2-
fold in either comparison. Of the probe signals, 92.4% (low
glucose) or 90.4% (high glucose) were in the range of −1.2-
to 1.2-fold.
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Using a fold change of 1.3 and a p of 0.05 as cut-off,
105 genes were found to be differentially expressed in
mature adipocytes by insulin treatment at low or high
glucose levels (Fig. 1). The overlap of the insulin-regulated
gene list between low and high glucose levels was small,
indicating an influence of glucose on the effect of insulin.
We used Q-PCR to confirm the mRNA change for 12 of the
differentially expressed genes and six of their family
members. A good correlation between array and Q-PCR
data was found (R2 =0.803). Three examples, procollagen-
proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxy-
lase), alpha 1 (P4ha1), procollagen C-endopeptidase
enhancer protein (Pcolce) and sulfatase 2 (Sulf2), are
shown (Fig. 2).
The 105 differentially expressed genes were clustered
into ten functional groups based on Gene Ontology
annotations (Fig. 3, ESM Table 2). One additional group
consisted of genes with unknown function. The largest
group was that of structural proteins and related enzymes,
consisting of genes with a functional annotation of
cytoskeleton, cell adhesion and extracellular matrix
(ECM) (Table 1). All genes of this functional group were
upregulated, except cysteine-rich protein 61. Sulf2, an
extracellular endosulfatase, showed the largest increase in
response to insulin (1.8-fold). This was not influenced by
the glucose state. Glucose alone had no effect on its
expression (Table 1, Fig. 2). The up-regulation of proteol-
ysis inhibitors, tissue inhibitor of metalloproteinases (Timp1
and Timp4), implies reduced degradation of ECM compo-
nents. The next major functional group was related to
protein expression. However, the upregulation or downreg-
ulation of individual genes involved in mRNA processing
and protein synthesis, folding, modification and transport
gave an inconsistent picture of the effect of insulin on
protein expression in general (ESM Table 2). For all groups
the insulin effect was more explicit with high glucose than
with low glucose, while glucose itself had no direct effect
on the expression of most of these genes. This implies that
regulation of these processes by insulin is dependent on the
level of glucose.
We analysed the expression of 38 genes on the array and
involved in insulin signalling pathways and found no
significant effect (ESM Table 3). Since insulin signal
transmission occurs mostly via phosphorylation of the
proteins, it is not surprising that our data showed no
significant influence on mRNA levels. One exception was
phosphatidylinositol 3-kinase, regulatory subunit, polypep-
tide 2 (p85 beta), which was upregulated by insulin (fold
change=1.22, p=0.046 and fold change=1.39, p=0.011 at
low and high glucose, respectively). It has been reported
that p85 beta negatively regulates the downstream signal-
ling of phosphatidylinositol 3-kinase [14]. Therefore, the
up-regulation of p85 beta suggests an attenuation of
particular insulin signalling pathways.
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Fig. 1 Number of genes regulated by insulin at low and high glucose
level. Based on microarray data, insulin and basal conditions were
compared to obtain the number of regulated genes for the low glucose
level; insulin+glucose and glucose conditions were compared for the
high glucose level. Cut–off criteria: fold change >1.3 and t-test p<0.05
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Fig. 2 Expression levels of genes involved in protein processing
measured by quantitative real-time PCR, relative to ribosomal protein
S15 (Rps15) expression. Dots, individual samples; bars, group
average (n=6). The fold change of Ins/Basal and Ins+Glc/Glc,
respectively, were for: (a) P4ha1 1.46 (p=0.008) and 1.48 (p=0.016);
(b) Pcolce 1.47 (p=0.007) and 1.34 (p=0.001); and (c) Sulf2 1.73 (p =
0.004) and 1.86 (p=0.003)
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Insulin modulates protein secretion from mature adipocytes
in vitro
No clear effect of insulin was seen on the expression of
genes encoding secreted proteins or proteins involved in
secretion pathways. To assess whether this would also be
the case at the protein level, we also analysed the secreted
proteins of an identical set of experiments performed in
parallel to those described for mRNA expression analysis
using 2D gel electrophoresis. Using a secretory protein map
of 3T3-L1 adipocytes [10], we identified 86 secreted spots
corresponding to 37 genes in the 10 to 85 kDa range. High-
molecular-weight proteins were left out of the analysis due
to overall low resolution in the high-molecular-weight part
of the gel. A strong effect of insulin on the expression of
secreted proteins was detected. A total of 63 spots (73.3%)
corresponding to 29 genes (78.4%) were upregulated or
downregulated by insulin at either high or low glucose
level. The majority of the secreted proteins were affected at
both high and low glucose levels (Table 2). The most
dominant change in the secretion profile was the increase of
the C-peptides of collagen type I and III, which are the
processing by-products of fibrillar collagens (Fig. 4).
To obtain information on the high-molecular weight
secretion profile, we used 1D gel electrophoresis. Three
bands that showed differential expression and were verified
as secreted by brefeldin A [10] were identified by MALDI-
TOF mass spectrometry. They contain ECM components
(procollagens and nidogen) and whole-chain complement
C3 (Fig. 5).
The combined secretion profiles showed that insulin
increases the secretion and processing of ECM components,
such as collagen type I, III, V, VI and nidogen. The up-
regulation of ECM processing is in line with the increased
secretion of processing enzymes and their regulators, such
as matrix metalloproteinase 2, metalloproteinase inhibitor
2 and procollagen C-endopeptidase enhancer protein
(Table 2). The secretion of most of the detected adipokines,
such as complement C3, adipsin, secreted acidic cysteine-
rich protein (SPARC), and pigment epithelium-derived
factor, was stimulated by insulin. The downregulated
secretory spots (Table 2) were all from intracellular proteins
[10], except adiponectin and galectin-1. Western blotting
confirmed that adiponectin was not upregulated by insulin,
but this technique also failed to show any significant
downregulation (data not shown).
Comparison of insulin effect on transcriptome
and proteome of secretory genes
Discriminant principal component analysis is a powerful
tool for illustrating the general effect of different treatments.
Discriminant principal component analysis of the 2D
secreted protein profile confirmed that, compared with
glucose alone, insulin generated a clear shift of the secreted
protein profile (Fig. 6a). In contrast, the transcription profile
of the 36 corresponding genes (nascent polypeptide-
associated complex alpha polypeptide gene was not
included due to its low expression) was hardly affected
(Fig. 6b).
The discrepancy between the effect of insulin at the
secreted protein level and the mRNA level as observed by
discriminant principal component analysis was verified by
zooming in on individual proteins/genes (Table 2). Of the
37 genes, 29 were changed by insulin treatment at the
secreted protein level. However, only four of them
(superoxide dismutase 3 extracellular, macrophage migra-
tion inhibitory factor, procollagen type V alpha 1 and
Pcolce) showed a comparable regulation at mRNA level,
while the others were not regulated at the transcriptional
level.
The strong increase of collagen C-peptides indicated
considerable regulation at the protein processing level. In
this respect, we found two interesting genes. Prolyl 4-
hydroxylase catalyses the first post-translational modifica-
tion (PTM) of collagen, resulting in the 4-hydroxylation of a
number of proline residues [15]. Active prolyl 4-hydroxy-
lase is a tetramer composed of two pairs of non-identical
subunits (α2β2). The concentration of alpha-subunit limits
the rate of formation of active enzyme [16]. Microarray
data, confirmed by Q-PCR, showed that the expression of
P4ha1 was significantly upregulated by insulin at both low
and high glucose levels (Fig. 2). Glucose itself had no
effect on this gene, indicating that this upregulation is
glucose-independent and insulin-specific. Cleavage of N-
and C-peptides is also an important step in fibrillar collagen
maturation. The C-endopeptidase enhancer protein
(PCOLCE) binds and drives the enzymatic cleavage of
type I procollagen [17]. Although the C-endopeptidase
0 5 10 15 20 25 30
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Fig. 3 Functional categories of genes regulated by insulin
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(Bmp1) was not changed, the upregulation of Pcolce
(Fig. 2) could lead to an increase in proteinase activity
and thus contribute significantly to the increased amount of
C-peptides in extracellular medium.
Discussion
We used transcriptomics and proteomics to reveal the effects
of insulin on adipocyte secretion. From a proteomics view,
insulin had a significant impact on protein secretion. However,
transcription is not the major regulation point for these
secreted proteins. A discrepancy between mRNA and protein
levels has been observed in other studies [18, 19]. In addition
to technical differences, the proposed molecular explanations
include polysome activation on mRNA, alternative mRNA
splicing, protein turnover, specific proteolytic processing and
PTMs [20]. Further, the discrepancy between transcript and
protein level largely depends on the nature of the proteins
studied. Maturation of the secreted proteins involves signif-
icant PTMs. For example, glycosylation and signal peptide
cleavage are common events for these proteins. A secreted
protein undergoes synthesis, modification, and transport
before it can be located to its destined extracellular space.
Therefore, it is reasonable to expect a low correlation
between its mRNA and secreted protein level.
Here, we go further and propose a biological role for this
discrepancy in the action of insulin. Insulin is a very potent
hormone that is precisely regulated both spatially and
temporally [21]. A highly effective means of regulating the
activity of target proteins involved in insulin signalling
pathways is phosphorylation, one form of PTM. Likewise,
PTM can also be used to efficiently promote the secretion
of proteins, as an alternative to upregulation of their
Table 1 Expression of cytoskeleton, adhesion and extracellular matrix genes regulated by insulin
Function Symbol GeneID Name Ins/basal Ins+Glc/Glc Glc/basal
FC p FC p FC p
Cytoskeleton
Tubb6 67951 Tubulin, beta 6 1.18 0.302 1.36 0.025 −1.14 0.230
Actin binding Cnn3 71994 Calponin 3, acidic 1.30 0.007 1.29 0.018 −1.10 0.230
Actin binding Tagln2 21346 Transgelin 2 1.40 0.033 1.45 0.011 −1.13 0.336
Adhesion
Postn 50706 Periostin, osteoblast specific factor 1.32 0.049 1.38 0.044 −1.23 0.170
Itga5 16402 Integrin alpha 5 1.11 0.365 1.42 0.001 −1.28 0.061
Cyr61 16007 Cysteine-rich protein 61 −1.01 0.880 −1.41 0.035 1.38 0.035
Sdc1 20969 Syndecan 1 1.22 0.187 1.51 0.006 −1.29 0.091
Cspg2 13003 Chondroitin sulfate proteoglycan 2 1.51 0.002 1.33 0.198 1.11 0.315
Proteoglycan
synthesis
Chst2 54371 Carbohydrate sulfotransferase 2 1.39 0.013 1.31 0.045 −1.13 0.240
Proteoglycan
hydrolysis
Sulf2 72043 Sulfatase 2 1.76 0.013 1.73 0.009 −1.02 0.804
Extracellular matrix
Tgfbi 21810 Transforming growth factor, beta induced 1.35 0.005 1.12 0.024 −1.18 0.012
Col5a1 12831 Procollagen, type V, alpha 1 1.11 0.290 1.32 0.018 −1.10 0.334
Col6a3 12835 Procollagen, type VI, alpha 3 1.25 0.001 1.47 0.009 −1.09 0.131
Col6a2 12834 Procollagen, type VI, alpha 2 1.11 0.116 1.31 0.029 −1.06 0.401
Col5a3 53867 Procollagen, type V, alpha 3 1.09 0.209 1.39 0.044 −1.26 0.073
Collagen process P4ha1 18451 Procollagen-proline 4-hydroxylase alpha 1
polypeptide
1.27 0.038 1.32 0.000 −1.00 0.904
Collagen process Loxl1 16949 Lysyl oxidase-like 1 1.25 0.064 1.31 0.005 1.00 0.942
Collagen process Pcolce 18542 Procollagen C-endopeptidase enhancer
protein
1.22 0.082 1.36 0.017 −1.12 0.332
Proteolysis
inhibitor
Timp1 21857 Tissue inhibitor of metalloproteinase 1 1.05 0.595 1.35 0.038 −1.22 0.188
Proteolysis
inhibitor
Timp4 110595 Tissue inhibitor of metalloproteinase 4 1.67 0.010 1.28 0.006 1.03 0.607
The expression, fold change (FC) and t-test p value (p) were calculated from microarray analysis (n=5)
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transcription. On the basis of our findings, insulin promotes
collagen protein secretion via the transcriptional upregula-
tion of enzymes involved in PTMs. Via processing
enzymes, this regulation can evoke a highly amplified
effect. For example PCOLCE, which was up-regulated in
this study, can enhance the activity of procollagen C-
endopeptidase up to 20-fold [17].
Besides an effect on collagens, increased processing
and other PTMs might also explain effects on other
secreted proteins, such as adipsin, SPARC and comple-
ment C3, which are highly upregulated by insulin at the
secretion level, but not at the mRNA level. Alternatively,
this could be explained by a general upregulation of
exocytosis.
Table 2 Expression of secreted proteins regulated by insulin
Protein secretion level mRNA level
Ins/basal Ins+Glc/Glc Ins/basal Ins+Glc/Glc
Protein description Overall Max
FC
Overall Max
FC
Gene FC p FC p
Downregulated proteins
Vimentin fragment – −4.6 – −13.9 Vim 1.17 0.016 1.11 0.187
Beta actin fragment – −7.6 – −6.8 Actb −1.12 0.077 1.20 0.028
Cofilin, non-muscle isoform – −1.9 ± −1.6 Cfl1 1.03 0.597 1.24 0.032
Gesolin fragment ± −1.5 − 3.9 Gsn 1.10 0.236 1.11 0.115
Adiponectin – −2.1 ± −1.5 Acdc −1.12 0.320 −1.03 0.852
ATP synthase D chain, mitochondrial – −2.1 – −2.9 Atp5h −1.24 0.861 1.03 0.744
Galectin-1 – −1.9 – −2.9 Lgals1 −1.03 0.937 1.01 0.881
Peroxiredoxin 1 – −8.5 – −6.6 Prdx1 1.09 0.241 1.03 0.801
Prohibitin – −4.0 – −5.0 Phb −1.07 0.392 1.08 0.437
Upregulated proteins
Collagen I alpha 1 fragment and C-terminal peptide + 31.9 + 51.0 Col1a1 1.11 0.442 1.23 0.160
Collagen I alpha 2 fragment and C-terminal peptide + 14.7 + 14.2 Col1a2 1.05 0.596 1.20 0.132
Collagen III alpha 1 fragment and C-terminal peptide + 3.4 + 7.0 Col3a1 1.17 0.170 1.16 0.134
Adipsin + 6.0 + 3.6 Adn −1.20 0.204 −1.11 0.397
Collagen V alpha 1 fragment + 3.5 + 4.8 Col5a1 1.11 0.290 1.32 0.018
Matrix metalloproteinase-2 + 11.7 ± 2.3 Mmp2 1.17 0.502 1.31 0.102
Procollagen C-endopeptidase enhancer protein + 4.2 + 7.3 Pcolce 1.22 0.082 1.36 0.017
Pigment epithelium-derived factor fragment + 3.2 + 1.9 Serpinf1 1.19 0.334 1.14 0.400
Heterogeneous nuclear 1 ribonucleoprotein A2/B1 ± 1.2 + ∝ Hnrpa2b1 1.02 0.928 1.00 0.964
Superoxide dismutase 3, extracellular ± −1.1 + 2.2 Sod3 1.07 0.473 1.38 0.040
Secreted acidic cysteine-rich glycoprotein + 7.0 + 4.2 Sparc 1.03 0.623 1.18 0.076
Metalloproteinase inhibitor 2 ± −1.1 + ∝ Timp2 −1.04 0.825 1.23 0.065
Possible downregulated proteins
Annexin A5, Coatomer protein subunit epsilon
(mixed with collagen III alpha 1 C-peptide)
− −3.1 − −4.0 Anxa5 1.02 0.813 1.04 0.893
Cope 1.14 0.180 1.11 0.362
Possible upregulated proteins
Protein-lysine 6-oxidase, alpha enolase fragment
(mixed with collagen I alpha 2)
+ ∝ + ∝ Lox 1.07 0.763 −1.04 0.787
+ ∝ + ∝ Eno1 1.20 0.079 1.21 0.157
Macrophage migration inhibitory factor
(mixed with beta-2 microglobulin)
+ 3.3 + 2.7 Mif 1.18 0.106 1.35 0.025
B2m −1.01 0.902 1.02 0.879
Nascent polypeptide associated complex alpha
(mixed with collagen V fragment)
+ 3.5 + 4.8 Naca undetectable signal on array
Nidogen (mixed with collagen I and VI) + (1D) + (1D) Nid1 1.04 0.529 1.09 0.293
Dual-regulated proteins
Complement C3 beta chain + 3.7 + 4.0 C3 1.10 0.191 1.13 0.223
– −2.3 – −7.2
Protein secretion levels were measured by 2D gel analysis (n=3) or by 1D analysis (1D) when indicated. When more than one spot had the same
protein identification, the total signal of all spots was used for comparison to show the overall change (+: increased, ± : no change, –: decreased)
and the fold change of the spot with the maximum change is given (Max FC). mRNA levels were measured by microarray analysis (n=5).
FC, fold change; ∝, spot appeared only in condition with insulin. p values are for t-test
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Using the 2D gel system to study adipocyte secretion in
mouse 3T3-L1 cells has several advantages and limitations,
as discussed previously [10]. Only part of the secretory
proteome is visualised. For instance, we were not able to
cover all known adipocyte-secreted proteins to address their
response to insulin and determine the relationship between
their mRNA and secretion levels. Further, the change of
protein quantity based on a single spot may be under-
estimated if a protein is present in several isoforms and thus
as several spots on the gel, or overestimated if one gel spot
contains more than one protein. Therefore we took all the
spots with the same identification into account and provide
information on mixed spots in Table 2. One major
advantage of 2D gel analysis is that it is useful for
visualising protein modifications. The different isoforms
and modifications can be separated on the basis of their
different isoelectric points and mol. wt. The importance of
processing and secondary modification as the effect of
Fig. 4 Collagen C peptides as
measured by 2D gel analysis in
(a) basal, (b) high glucose,
(c) high insulin and (d) high
insulin high glucose conditions.
A section of one representative
2D gel image per condition is
shown. Circles, collagen I alpha
1 C-peptide; squares, collagen
III alpha 1 C-peptide; diamonds,
collagen I alpha 2 C-peptide
Fig. 5 Differentially expressed high-molecular-weight proteins as
measured by 1D gel analysis. One representative image is shown. A
sample treated with brefeldin A (+BFA) was used to verify secretion.
Band 1: procollagen I alpha 1+ procollagen III alpha 1; band 2:
nidogen+procollagen I alpha 2+collagen VI alpha 2; band 3:
complement C3
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Fig. 6 Discriminant principal component analysis (a) of secreted
proteins on the secretion pattern by 2D gel analysis, and (b) of
matched mRNAs on the expression pattern by microarray analysis.
One symbol represents one sample profile in the groups of basal (0),
insulin (Ì), glucose (r) or insulin+glucose ())
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insulin is illustrated by the 2D analysis of the C-peptides
of collagens. Another example is that the beta chain of
complement C3 had three spots on the gel [10]. Two spots
were upregulated, as was the C3 complete chain on 1D gel,
and one spot was downregulated by insulin, indicating
different modifications. Detailed information about the
modifications may provide more insight into the exact
effect of insulin on the expression and function of these
proteins.
Insulin promotes cell survival and anti-apoptosis [22,
23]. Numerous studies have shown that cell survival and
death strongly depend on cell adhesion and the ECM [24,
25]. Our previous work showed that ECM components
represent a major part of the proteins secreted from 3T3-L1
adipocytes in vitro [10]. We propose that the upregulation
of secretion of ECM components, together with the
increased gene expression of adhesion molecules (Table 1)
by insulin, contributes to a strengthened survival of in vitro
cultured adipocytes. Since in vivo adipocytes are intensive-
ly supported by the basement membrane [26], insulin may
similarly affect adipocyte survival in vivo.
Apart from adiponectin and galectin, the downregulated
proteins in the medium are not genuine secreted proteins.
As a reflection of secreted proteinase activity, their presence
in the medium may be caused by leakage and shedding
[10]. In view of the improved cell survival, it is not
surprising to see a decrease of leaked cellular proteins. The
difference from other genuine secreted proteins implies that
secretion of adiponectin and galectin 1 is regulated by
insulin in a different way. This may be consistent with the
finding that adiponectin and collagen VI alpha 3 are in two
distinct exocytosis compartments [7].
Here, we report for the first time that Sulf2 expression is
significantly upregulated by insulin in 3T3-L1 adipocytes
in vitro. Sulf2 belongs to the family of extracellular
endosulfatases that are able to remodel the 6-O sulfation
state of cell surface heparan sulfate proteoglycans (HSPG).
Again, its regulation shows that transcription of PTM
enzyme genes is a target of insulin in adipocytes. The
human SULF2 (KIAA1247) gene is located in a type 2
diabetes susceptibility region on human chromosome 20
[27]. HSPG has been implicated in diverse physiological
processes [28–31] by binding ligands for which the specific
structure and/or negative charge of the heparan sulfate
chain is instrumental [32]. It has already been reported that
de-sulfation of HSPG accounts for altered function. For
example, avian QSULF1, a family member of Sulf2,
inhibited angiogenesis in vitro [33]. Analogously, de-
sulfation triggered by insulin via Sulf2 may induce
functional changes in adipocytes. Interestingly, reduced
amounts and an altered function of HSPG have been
extensively reported in patients with type 2 and also type 1
diabetes [34, 35]. The decrease of HSPG and their sulfation
in diabetes may be due to a decrease of N-deacetylase [36],
possibly induced by a high glucose level [37]. However,
others have shown that high glucose only diminished the
level of HSPG without significant changes in N-deacetylase
and sulfation (especially N-sulfation) in cultured 3T3-L1
adipocytes [38]. Besides glucose, insulin has also been
considered to underlie alteration of HSPG. The 35S labelled
HSPG from liver were lower in obese and insulin-resistant
Zucker rats than in their unaffected littermates [39]. Our
results suggest that besides glucose, insulin might indepen-
dently induce a pattern change in HSPG in cultured
adipocytes. Immunocytochemical analysis with the anti-
body 10E4 (Seikagaku, Tokyo, Japan) has been used to
assay the 6-O de-sulfation by transfected Qsulf1 in 3T3-L1
fibroblasts [40]. Using this antibody, we failed to detect a
significant decrease of HSPG sulfation in 3T3-L1 mature
adipocytes after treatment with insulin (data not shown).
However, the 10E4 antibody may not be able to properly
recognise 6-O sulfation [41].
In conclusion, we used a combined transcriptomic and
proteomic approach to study the effect of insulin on mature
3T3-L1 adipocytes focusing on secreted proteins. Interest-
ingly, we observed that insulin has a large effect on
secretion but not on transcription of secreted protein genes.
This discrepancy may be partly explained by the transcrip-
tional upregulation of processing protein genes. It reveals
that PTM is induced by insulin not only in signal
transduction, but also in the regulation of secretion.
Determination of quantity and activity of the PTM-enzymes
will further support this hypothesis. Our study is one of the
first to use transcriptomics and proteomics, and clearly
demonstrates the added value of a combined genomics
approach to the study of biological mechanisms.
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